KLAS Contact
Contact KLAS
Contact KLAS
2024 BEST IN KLAS
Preferences
Related Series
2020
2018
2012
Clinical Mobility Shared Smart Devices 2024
How Well Do Retail & Commercial-Grade Devices Meet Healthcare-Specific Needs?
Author
Paul Hess
Author
Paul Warburton
Healthcare organizations are continually expanding their use of smart devices, but their unique needs for durability, healthcare-centric workflows, and low costs can present challenges for both users and the organizations purchasing the devices. While many healthcare organizations opt for BYOD programs in specific departments, several are adopting shared smart device programs. Based on interviews from 80 healthcare organizations using such programs,†this report examines (1) smart device vendors’ market penetration and ability to meet healthcare needs and (2) customer satisfaction with vendors who have sufficient performance data.
†KLAS specifically asked interviewed organizations about their shared smart device programs. Some respondents may also utilize corporate-issued personal-use devices.
If you don't have a login, getting started is easy.
Key Findings:
- Apple Used Broadly by Healthcare Organizations; Samsung Growth Slows
- Ascom, Spectralink & Zebra Technologies Seen as Expensive Options for Healthcare-Specific Capabilities
- Healthcare Organizations Using Apple iPad Are Most Highly Satisfied; iPhone Provides Strong Camera but Weak Battery Life
- Zebra Technologies* Provides Strong Security & Privacy Features; Customers Say TC52-HC’s High Cost Impedes Value
*Limited data
Writer
Natalie Hopkins
Designer
Breanne Hunter
Project Manager
Andrew Wright
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.